| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
208,785,000 |
| Market
Cap: |
47.84(B) |
| Last
Volume: |
1,348,221 |
Avg
Vol: |
0 |
| 52
Week Range: |
$177.16 - $259.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 785 |
| Guru Rank Value : 1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile IQVIA Holdings is a provider of analytics, technology solutions, and clinical research services to the life sciences industry. Co. is managed through three reportable segments: Technology and Analytics Solutions, which provides information, technology solutions and real-world insights and services to its life science clients; Research and Development Solutions, which primarily serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services; and Contract Sales and Medical Solutions, which provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the healthcare market.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
68,853 |
81,970 |
115,108 |
120,554 |
| Total Sell Value |
$17,072,068 |
$19,879,540 |
$26,755,079 |
$27,988,147 |
| Total People Sold |
4 |
4 |
5 |
5 |
| Total Sell Transactions |
5 |
6 |
9 |
11 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bousbib Ari |
See Remarks |
• • – |
2020-06-02 |
4 |
AS |
$150.11 |
$24,749,686 |
D/D |
(164,877) |
652,035 |
|
10% |
|
| Bousbib Ari |
See Remarks |
• • – |
2020-06-02 |
4 |
A |
$8.34 |
$2,179,330 |
D/D |
164,877 |
816,912 |
|
- |
|
| Bousbib Ari |
See Remarks |
• • – |
2020-06-01 |
4 |
AS |
$150.00 |
$2,916,450 |
D/D |
(19,443) |
652,035 |
|
10% |
|
| Bousbib Ari |
See Remarks |
• • – |
2020-06-01 |
4 |
A |
$15.11 |
$293,784 |
D/D |
19,443 |
671,478 |
|
- |
|
| Goggins Colleen A |
Director |
– • – |
2020-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,492 |
7,251 |
|
- |
|
| Burt Carol |
Director |
– • – |
2020-05-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,492 |
2,970 |
|
- |
|
| Danhakl John G |
Director |
– • – |
2020-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,492 |
2,970 |
|
- |
|
| Leonard John M. |
Director |
– • – |
2020-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,492 |
9,744 |
|
- |
|
| Rittenmeyer Ronald A |
Director |
– • – |
2020-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,492 |
62,277 |
|
- |
|
| Evanisko Michael J |
Director |
– • – |
2020-03-24 |
4 |
OE |
$21.20 |
$139,920 |
I/I |
6,600 |
11,850 |
|
- |
|
| Staub W Richard |
See Remarks |
• – – |
2020-03-03 |
4 |
D |
$141.36 |
$36,612 |
D/D |
(259) |
12,470 |
|
- |
|
| Knightly Kevin C |
See Remarks |
• – – |
2020-02-21 |
4 |
S |
$163.43 |
$358,075 |
D/D |
(2,191) |
0 |
|
13% |
|
| Connaughton John |
Director |
– • – |
2020-02-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,764 |
0 |
|
- |
|
| Connaughton John |
Director |
– • – |
2020-02-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(68,228) |
617,484 |
|
- |
|
| Knightly Kevin C |
See Remarks |
• – – |
2020-02-19 |
4 |
S |
$165.09 |
$939,032 |
D/D |
(5,688) |
2,191 |
|
16% |
|
| Staub W Richard |
See Remarks |
• – – |
2020-02-18 |
4 |
D |
$165.42 |
$1,434,853 |
D/D |
(8,674) |
12,729 |
|
- |
|
| Staub W Richard |
See Remarks |
• – – |
2020-02-18 |
4 |
S |
$163.77 |
$2,382,854 |
D/D |
(14,550) |
21,403 |
|
18% |
|
| Staub W Richard |
See Remarks |
• – – |
2020-02-18 |
4 |
OE |
$78.21 |
$1,425,299 |
D/D |
18,224 |
35,953 |
|
- |
|
| Connaughton John |
Director |
– • – |
2020-02-13 |
4 |
S |
$164.30 |
$115,638,940 |
I/I |
(703,828) |
685,712 |
|
18% |
|
| Coulter James G |
Director |
– • – |
2020-02-13 |
4 |
S |
$164.30 |
$492,271,060 |
I/I |
(2,996,172) |
2,919,051 |
|
18% |
|
| Knightly Kevin C |
See Remarks |
• – – |
2020-02-11 |
4 |
D |
$161.70 |
$520,997 |
D/D |
(3,222) |
7,879 |
|
- |
|
| Knightly Kevin C |
See Remarks |
• – – |
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
8,910 |
11,101 |
|
- |
|
| Staub W Richard |
See Remarks |
• – – |
2020-02-11 |
4 |
D |
$161.70 |
$498,198 |
D/D |
(3,081) |
17,729 |
|
- |
|
| Staub W Richard |
See Remarks |
• – – |
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
8,910 |
20,810 |
|
- |
|
| Bousbib Ari |
See Remarks |
• • – |
2020-02-11 |
4 |
D |
$161.70 |
$6,047,742 |
D/D |
(37,401) |
652,035 |
|
- |
|
490 Records found
|
|
Page 7 of 20 |
|
|
2.10 (0.92%) 
